Selling of Delta 8 THC Infringement warning:
Five businesses received warning letters from the FDA on May 4, 2022, for selling items marked as containing delta-8 THC in ways that contravened the Federal Food, Drug, and Cosmetic Act (FD&C Act). These warning letters, the first for products containing delta-8 THC, were prompted by reports of adverse events suffered by patients who had consumed these products and the risk of its psychoactive and intoxicating effects. Warning Letter Specifications: The warning letters specifically talk about how businesses are illegally promoting unapproved delta-8 THC products as unapproved therapies for various illnesses or other therapeutic applications under the FD&C Act. The letters also mention drug misbranding offenses, such as inadequate product instructions, the inclusion of delta-8 THC in meals, and worries that the goods would appeal to youngsters. Key Takeaways: Delta 8 THC has rapidly gained popularity. Delta 8 is a respectable substitute for ordinary weed for novic...